vTv Therapeutics (VTVT) Announces Completion of Phase 2 LOGRA Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to vTv Therapeutics (VTVT) Announces Completion of Phase 2 LOGRA Enrollment

vTv Therapeutics (VTVT) Reports Q2 Loss of $0.47/Share

August 16, 2016 7:28 AM EDT

vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($0.47). Revenue for the quarter came in at $182 thousand, versus $110 thousand reported last year.

Cash, cash equivalents and marketable securities as of June 30, 2016 were $63.8 million, compared to $88.0 million as of December 31, 2015. The Company expects that its cash,... More